Patients and Methods
Abbreviations and Acronyms:BP (blood pressure), BMI (body mass index), CAD (coronary artery disease), HRT (hormone replacement therapy), MCSA (Mayo Clinic Study of Aging), NSAID (nonsteroidal anti-inflammatory drug), OR (odds ratio)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- CBTRUS Statistical Report: Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012.Neuro Oncol. 2015; 17: iv1-iv62
- Incidental meningiomas in autopsy study.Surg Neurol. 1987; 27: 319-322
- Epidemiology of meningiomas post-Public Law 107-206: the Benign Brain Tumor Cancer Registries Amendment Act.Cancer. 2015; 121: 2400-2410
- Meningiomas: knowledge base, treatment outcomes, and uncertainties: a RANO review.J Neurosurg. 2015; 122: 4-23
- Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA).Cancer. 2004; 100: 1208-1212
- The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.Neuroepidemiology. 2008; 30: 58-69
- Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets.Cancer Discov. 2015; 5: 1164-1177
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.Neurology. 2012; 78 ([published correction appears in Neurology. 2017;89(9):980]): 1576-1582
- Neurocognition in individuals with incidentally-identified meningioma.J Neurooncol. 2017; 134: 125-132
- The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.Br J Psychiatry. 1968; 114: 797-811
- The short test of mental status: correlations with standardized psychometric testing.Arch Neurol. 1991; 48: 725-728
- Manual for the Beck Depression Inventory-II.Psychological Corporation, San Antonio, TX1996
- Beck Anxiety Inventory Manual.Psychological Corporation, San Antonio, TX1993
- Incidental findings on brain MRI in the general population.N Engl J Med. 2007; 357: 1821-1828
- Body mass index, physical activity, and risk of adult meningioma and glioma: a meta-analysis.Neurology. 2015; 85: 1342-1350
- Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study.Neuro Oncol. 2011; 13: 1011-1019
- Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study.Acta Oncol. 2017; 56: 1302-1309
- Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.Cancer Epidemiol Biomarkers Prev. 2010; 19: 2562-2569
- Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.Int J Cancer. 2015; 136: 2369-2377
- Diabetes, use of metformin, and the risk of meningioma.PLoS One. 2017; 12: e0181089
- Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality.Br J Cancer. 2016; 115: 108-114
- Body fatness and cancer—viewpoint of the IARC Working Group.N Engl J Med. 2016; 375: 794-798
- Pathology and molecular genetics of meningioma: recent advances.Neurol Med Chir (Tokyo). 2015; 55: 14-27
- Nervous system and intracranial tumour incidence by ethnicity in England, 2001-2007: a descriptive epidemiological study.PLoS One. 2016; 11: e0154347
- Do race and age vary in non-malignant central nervous system tumor incidences in the United States?.J Neurooncol. 2017; 134: 269-277
Grant Support: This study was supported by a grants U01 AG006786, AG041851, and AG011378 from the National Institutes of Health , the GHR Foundation , Mayo Foundation for Medical Education and Research , and the Mayo Clinic Department of Psychiatry and Psychology small grants program.
Potential Competing Interests: Dr Petersen is a consultant for F. Hoffmann-La Roche LTD, Merck & Co., Inc, Genentech, Inc, GE Healthcare, and Biogen. Dr Jack is a consultant for Eli Lilly and Company, and serves on an independent data monitoring board for Roche but he receives no personal compensation from any commercial entity; he receives research support from the National Institutes of Health and the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. Dr Roberts has received grants from F. Hoffmann-La Roche LTD and Biogen; funding from these organizations was paid to Mayo Clinic for work unrelated to the current article. Dr Brown reports personal fees from UpToDate (contributor), and personal fees from Novella Clinical (DSMB member) outside the submitted work. The other authors report no competing interests.